Dr Reddy’s inks licensing deal to sell Immutep’s cancer drug
Dr Reddy’s has signed an exclusive licensing deal with Australia’s Immutep to make, develop and distribute the company’s cancer treatment, according to a stock exchange filing on Monday. The agreement,…
Dr Reddy’s gets over Rs 2,395 crore show cause notice from I-T authority
Dr Reddy’s Laboratories Ltd on Saturday said it has received a showcause notice from the income tax authority with a proposed demand of over Rs 2,395 crore from it related…
US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy’s slump 2-4%
Share of pharma companies saw red on February 14 as caution over the possibility of US tariffs hitting the sector spread across the Street. This came after US President Donald…
Sun Pharma Dropped In Market After Us Lawsuit
Share prices of some leading domestic pharmaceutical companies, led by Sun Pharmaceutical Industries, fell 4-9 per cent on Monday, after being named in a price-fixing lawsuit in the US. The…
1.7 LAKH BOTTLES OF TABLETS RECALLED BY LUPIN & DR. REDDY’S
New Delhi – Drug majors Lupin and Dr. Reddy’s are recalling over 1.7 lakh bottles of two different tablets, used in the treatment of blood pressure and acidity, in the…
